YES1

From WikiMD's Wellness Encyclopedia


YAP1 (Yes-associated protein 1) is a transcriptional co-activator and a key regulator of the Hippo signaling pathway, which is crucial for controlling organ size, cell proliferation, and apoptosis. YAP1 is encoded by the YAP1 gene in humans and is involved in various cellular processes, including development, tissue regeneration, and cancer.

Structure[edit | edit source]

YAP1 is a protein that contains several important domains:

  • The TEAD-binding domain, which allows YAP1 to interact with TEAD transcription factors.
  • The WW domain, which mediates protein-protein interactions by binding to proline-rich motifs.
  • The SH3-binding motif, which is involved in interactions with SH3 domain-containing proteins.
  • The PDZ-binding motif, which allows interaction with PDZ domain-containing proteins.

Function[edit | edit source]

YAP1 functions primarily as a transcriptional co-activator. It does not bind DNA directly but interacts with transcription factors such as TEAD to regulate gene expression. YAP1 activity is regulated by the Hippo signaling pathway, which controls its localization and stability.

Role in the Hippo Pathway[edit | edit source]

In the Hippo pathway, YAP1 is phosphorylated by the LATS1/2 kinases, leading to its retention in the cytoplasm and subsequent degradation. When the Hippo pathway is inactive, YAP1 translocates to the nucleus, where it interacts with TEAD transcription factors to promote the expression of genes involved in cell proliferation and survival.

Clinical Significance[edit | edit source]

YAP1 is implicated in various diseases, particularly cancer. Overexpression or hyperactivation of YAP1 has been observed in several types of cancer, including liver, breast, and colorectal cancers. YAP1 promotes tumor growth and metastasis by enhancing cell proliferation and inhibiting apoptosis.

YAP1 in Cancer[edit | edit source]

YAP1 acts as an oncogene in many cancers. Its overactivity can lead to uncontrolled cell growth and resistance to cell death, contributing to tumorigenesis. Targeting YAP1 and its interactions is a potential therapeutic strategy in cancer treatment.

Research and Therapeutic Potential[edit | edit source]

Research on YAP1 is ongoing to better understand its role in development and disease. Inhibitors of YAP1-TEAD interaction are being explored as potential cancer therapies. Additionally, YAP1 is being studied for its role in tissue regeneration and repair.

Also see[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD